Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Remdesivir
IL-1
Approved by FDA Experimental Antiviral Jan/18/2023
REGEN-COV
IL-1
Emergency use authorization Experimental Antiviral Jun/03/2022
Anakinra 
IL-1
Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Dexamethasone
IL-1
Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
Tocilizumab
IL-1
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
IL-1
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Corticosteroids
IL-1
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021
Siltuximab
IL-1
Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/29/2021
Ruxolitinib
IL-1
Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021
Acetylsalicylic acid
IL-1
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
IVIg
IL-1
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Sarilumab 
IL-1
Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/29/2021
Canakinumab
IL-1
Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/19/2021
Nigellidine
IL-1
Potential treatment - theoretical effect Natural product Antiviral Sep/02/2020
Autologous conditioned serum
IL-1
Potential treatment - clinical evidence Experimental Other treatment Aug/20/2020